drugset / Trial / NCT04555733
A Single and Multiple Dose Study of Lemborexant in Healthy Chinese Participants
Non-randomizedParallel-groupOpen-labelOther
Summary
The primary objective of this study is to assess the pharmacokinetics (PK) of lemborexant and metabolites (M4, M9, and M10) in plasma in healthy Chinese participants following single and multiple oral doses of lemborexant.
Timeline
- Start
- 2020-10-26
- Primary completion
- 2021-01-13
- Completion
- 2021-01-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lemborexant | Small molecule | 5 mg | Oral |
| Subject | Lemborexant | Small molecule | 10 mg | Oral |
| Subject | Lemborexant | Small molecule | 25 mg | Oral |
Indications
No indication recorded.